Heart heart failure with preserved ejection fraction-Update 2022 br

被引：0

作者：

Gerges, M. ^{[1
]}

Bonderman, D. ^{[1
,2
]}

机构：

[1] Wiener Gesundheitsverbund, 5 Med Abt mit Kardiol, Klin Favoriten, Vienna, Austria

[2] Wiener Gesundheitsverbund, Med Abt mit Kardiol 5, Klin Favoriten, Kundratstr 3, A-1100 Vienna, Austria

来源：

JOURNAL FUR KARDIOLOGIE | 2023年 / 30卷 / 1-2期

关键词：

heart failure with preserved ejection fraction (HFpEF); sodium-glucose cotransporter 2 inhibitor (SGLT2-i); angiotensin receptor neprilysin inhibitor (ARNI); 20-YEAR TRENDS; EPIDEMIOLOGY; HOSPITALIZATION; PREVALENCE; OUTCOMES; DIAGNOSIS; SURVIVAL; SEX; RECOMMENDATIONS; SPIRONOLACTONE;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Heart heart failure with preserved ejection fraction - Update 2022.. Until now no treatment had convincingly shown a reduction in mortality and morbidity in heart failure with preserved ejection fraction (HFpEF). The EMPEROR -Preserved trial, empagliflozin in HFpEF, is the first positive outcome study that reduced the combined risk for cardiovascular death or hospitalization, whether suffering from type 2 diabetes or not [1]. The DELIVER study, dapagliflozin in HFpEF, significantly reduced the primary endpoint of cardiovascular death or worsening in heart failure with mildly reduced ejection fraction (HFmrEF) or HFpEF [2, 3]. Current ESC guidelines further recommend the use of sacubitril/valsar tan and spironolactone in HFmrEF patients. Supporting data were provided by a sub-group analysis of the PARAGON-HF study showing a reduction in HF-related hospitalizations and a meta-analysis of the PARADIGM-HF and PARAGON-HF studies showing a reduction in cardiovascular deaths and HF-related hospitalizations

引用

页码：18 / 23

页数：8

共 82 条

[1] Effects of digoxin on morbidity and mortality in diastolic heart failure: The ancillary Digitalis Investigation Group trial [J].

Ahmed, Ali ;

Rich, Michael W. ;

Fleg, Jerome L. ;

Zile, Michael R. ;

Young, James B. ;

Kitzman, Dalane W. ;

Love, Thomas E. ;

Aronow, Wilbert S. ;

Adams, Kirkwood F., Jr. ;

Gheorghiade, Mihai .

CIRCULATION, 2006, 114 (05) :397-403

[2] Validation of the HFA-PEFF score for the diagnosis of heart failure with preserved ejection fraction [J].

Aizpurua, Arantxa Barandiaran ;

Sanders-van Wijk, Sandra ;

Brunner-La Rocca, Hans-Peter ;

Henkens, Michiel ;

Heymans, Stephane ;

Beussink-Nelson, Lauren ;

Shah, Sanjiv J. ;

van Empel, Vanessa P. M. .

EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (03) :413-421

[3] Guidelines Diagnosis and management of adults with chronic heart failure: summary of updated NICE guidance [J].

Al-Mohammad, Abdallah ;

Mant, Jonathan ;

Laramee, Philippe ;

Swain, Sharon .

BRITISH MEDICAL JOURNAL, 2010, 341

[4] Empagliflozin in Heart Failure with a Preserved Ejection Fraction [J].

Anker, Stefan D. ;

Butler, Javed ;

Filippatos, Gerasimos ;

Ferreira, Joao P. ;

Bocchi, Edimar ;

Boehm, Michael ;

Brunner-La Rocca, Hans-Peter ;

Choi, Dong-Ju ;

Chopra, Vijay ;

Chuquiure-Valenzuela, Eduardo ;

Giannetti, Nadia ;

Gomez-Mesa, Juan Esteban ;

Janssens, Stefan ;

Januzzi, James L. ;

Gonzalez-Juanatey, Jose R. ;

Merkely, Bela ;

Nicholls, Stephen J. ;

Perrone, Sergio V. ;

Pina, Ileana L. ;

Ponikowski, Piotr ;

Senni, Michele ;

Sim, David ;

Spinar, Jindrich ;

Squire, Iain ;

Taddei, Stefano ;

Tsutsui, Hiroyuki ;

Verma, Subodh ;

Vinereanu, Dragos ;

Zhang, Jian ;

Carson, Peter ;

Lam, Carolyn Su Ping ;

Marx, Nikolaus ;

Zeller, Cordula ;

Sattar, Naveed ;

Jamal, Waheed ;

Schnaidt, Sven ;

Schnee, Janet M. ;

Brueckmann, Martina ;

Pocock, Stuart J. ;

Zannad, Faiez ;

Packer, Milton .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (16) :1451-1461

[5]

[Anonymous], RESULTS DELIVER DAPA

[6] Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction The VITALITY-HFpEF Randomized Clinical Trial [J].

Armstrong, Paul W. ;

Lam, Carolyn S. P. ;

Anstrom, Kevin J. ;

Ezekowitz, Justin ;

Hernandez, Adrian F. ;

O'Connor, Christopher M. ;

Pieske, Burkert ;

Ponikowski, Piotr ;

Shah, Sanjiv J. ;

Solomon, Scott D. ;

Voors, Adriaan A. ;

She, Lilin ;

Vlajnic, Vanja ;

Carvalho, Francine ;

Bamber, Luke ;

Blaustein, Robert O. ;

Roessig, Lothar ;

Butler, Javed .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (15) :1512-1521

[7] Ethnic-Specific Normative Reference Values for Echocardiographic LA and LV Size, LV Mass, and Systolic Function The EchoNoRMAL Study [J].

Aune, E. ;

Brown, A. ;

Badano, L. P. ;

Cameron, V. ;

Chadha, D. S. ;

Chahal, N. ;

Chien, K. L. ;

Daimon, M. ;

Dalen, H. ;

Detrano, R. ;

Duzenli, M. Akif ;

Ezekowitz, J. ;

de Simone, G. ;

Di Pasquale, P. ;

Fukuda, S. ;

Gill, P. S. ;

Grossman, E. ;

Hobbs, F. D. R. ;

Kim, H. -K. ;

Kuznetsova, T. ;

Leung, N. K. W. ;

Linhart, A. ;

McDonagh, T. A. ;

McGrady, M. ;

McMurray, J. J. V. ;

Mill, J. G. ;

Mogelvang, R. ;

Muiesan, M. L. ;

Ng, A. C. T. ;

Ojji, D. ;

Otterstad, J. E. ;

Petrovic, D. J. ;

Poppe, K. K. ;

Prendergast, B. ;

Rietzschel, E. ;

Schirmer, H. ;

Schvartzman, P. ;

Senior, R. ;

Simova, I. ;

Sliwa, K. ;

Stewart, S. ;

Squire, I. B. ;

Takeuchi, M. ;

Thomas, L. ;

Whalley, G. A. ;

Altman, D. G. ;

Perera, R. ;

Poppe, K. K. ;

Triggs, C. M. ;

Yeung, H. Au .

JACC-CARDIOVASCULAR IMAGING, 2015, 8 (06) :656-665

[8] Heart failure in young adults: 20-year trends in hospitalization, aetiology, and case fatality in Sweden [J].

Barasa, Anders ;

Schaufelberger, Maria ;

Lappas, Georgios ;

Swedberg, Karl ;

Dellborg, Mikael ;

Rosengren, Annika .

EUROPEAN HEART JOURNAL, 2014, 35 (01) :25-32

[9]

Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI [10.1161/CIR.0000000000000659, 10.1161/CIR.0000000000000746]

[10]

Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI [10.1161/CIR.0000000000000485, 10.1161/CIR.0000000000000530, 10.1161/CIR.0000000000000558]

← 1 2 3 4 5 6 7 8 9 →